The role of 18F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 11, 2010, Pages 2037-2047

  Dijkman, Bernadette G ^a   Schuurbiers, Olga C J ^a   Vriens, Dennis ^a   Looijen Salamon, Monika ^a   Bussink, Johan ^a   Timmer Bonte, Johanna N H ^a   Snoeren, Miranda M ^a   Oyen, Wim J G ^a   Van Der Heijden, Henricus F M ^a   De Geus Oei, Lioe Fee ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CT; FDG PET; Lung cancer; Metastatic disease; Second primary tumour; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MESOTHELIOMA; PRIMARY TUMOR; RETROSPECTIVE STUDY; SECOND CANCER; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; WHOLE BODY PET;

AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 77958487267     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1505-2     Document Type: Article

References (42)

1. JR Molina P Yang SD Cassivi SE Schild AA Adjei 2008 Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Mayo Clin Proc 83 584 594 10.4065/83.5.584 18452692
2. LB Travis 2006 The epidemiology of second primary cancers Cancer Epidemiol Biomarkers Prev 15 2020 2026 10.1158/1055-9965.EPI-06-0414 17057028
3. I Soerjomataram JW Coebergh 2009 Epidemiology of multiple primary cancers Methods Mol Biol 471 85 105 10.1007/978-1-59745-416-2-5 19109776
4. MT van Rens P Zanen A Brutel de La Rivière HR Elbers HA van Swieten JM van Den Bosch 2000 Survival in synchronous vs. single lung cancer: upstaging better reflects prognosis Chest 118 952 958 10.1378/chest.118.4.952 11035662
5. RJ Battafarano BF Meyers TJ Guthrie JD Cooper GA Patterson 2002 Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival Ann Thorac Surg 74 988 993 10.1016/S0003-4975(02)03878-X 12400733
6. AK Ng LB Travis 2008 Subsequent malignant neoplasms in cancer survivors Cancer J 14 429 434 10.1097/PPO.0b013e31818d8779 19060610
7. R Aguiló F Macià M Porta M Casamitjana J Minguella AM Novoa 2008 Multiple independent primary cancers do not adversely affect survival of the lung cancer patient Eur J Cardiothorac Surg 34 1075 1080 10.1016/j.ejcts.2008.08.004 18824369
8. WG Douglas NR Rigual TR Loree SM Wiseman S Al-Rawi WL Hicks Jr 2003 Current concepts in the management of a second malignancy of the lung in patients with head and neck cancer Curr Opin Otolaryngol Head Neck Surg 11 85 88 10.1097/00020840-200304000-00004 14515084
9. GA Silvestri MK Gould ML Margolis LT Tanoue D McCrory E Toloza, et al. 2007 Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition) Chest 132 178S 201S 10.1378/chest.07-1360 17873168
10. PP Leong B Rezai WM Koch A Reed D Eisele DJ Lee, et al. 1998 Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma J Natl Cancer Inst 90 972 977 1:STN:280:DyaK1czivVSrsw%3D%3D 10.1093/jnci/90.13.972 9665144
11. MJ Koppe FA Zoetmulder N van Zandwijk AA Hart P Baas EJ Rutgers 2001 The prognostic significance of a previous malignancy in operable non-small cell lung cancer Lung Cancer 32 47 53 1:STN:280:DC%2BD3MzisVGktA%3D%3D 10.1016/S0169-5002(00)00208-7 11282428
12. YL Chang CT Wu YC Lee 2007 Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients J Thorac Cardiovasc Surg 134 630 637 10.1016/j.jtcvs.2007.06.001 17723810
13. DC Chhieng JF Cangiarella MF Zakowski S Goswami JM Cohen HT Yee 2001 Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens Cancer 93 330 336 1:CAS:528: DC%2BD3MXot1Oqu7s%3D 10.1002/cncr.9048 11668468
14. MG van Oijen FG Leppers Vd Straat MG Tilanus PJ Slootweg 2000 The origins of multiple squamous cell carcinomas in the aerodigestive tract Cancer 88 884 893 10.1002/(SICI)1097-0142(20000215)88:4<884::AID-CNCR20>3.0.CO;2-S 10679659
15. MT van Rens EJ Eijken JR Elbers JW Lammers MG Tilanus PJ Slootweg 2002 p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma Cancer 94 188 196 10.1002/cncr.10001 11815976
16. LF de Geus-Oei JH van Krieken RP Aliredjo PF Krabbe C Frielink AF Verhagen, et al. 2007 Biological correlates of FDG uptake in non-small cell lung cancer Lung Cancer 55 79 87 10.1016/j.lungcan.2006.08.018 17046099
17. RJ Cerfolio AS Bryant B Ohja AA Bartolucci 2005 The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival J Thorac Cardiovasc Surg 130 151 159 10.1016/j.jtcvs.2004.11.007 15999056
18. HJ Jeong JJ Min JM Park JK Chung BT Kim JM Jeong, et al. 2002 Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer Nucl Med Commun 23 865 870 1:CAS:528:DC%2BD38Xntlyhsbo%3D 10.1097/00006231- 200209000-00010 12195091
19. H Vesselle A Salskov E Turcotte L Wiens R Schmidt CD Jordan, et al. 2008 Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index J Thorac Oncol 3 971 978 10.1097/JTO.0b013e31818307a7 18758298
20. K Higashi Y Ueda K Ayabe A Sakurai H Seki Y Nambu, et al. 2000 FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features Nucl Med Commun 21 707 714 1:STN:280: DC%2BD3cvovVCqsA%3D%3D 10.1097/00006231-200008000-00002 11039452
21. M Soret SL Bacharach I Buvat 2007 Partial-volume effect in PET tumor imaging J Nucl Med 48 932 945 10.2967/jnumed.106.035774 17504879
22. JA Swets 1988 Measuring the accuracy of diagnostic systems Science 240 1285 1293 1:STN:280:DyaL1c3jsF2jtQ%3D%3D 10.1126/science.3287615 3287615
23. SY Jeon SH Ahn CH Kim SM Lim JS Koh JC Lee 2008 Esophageal and laryngeal cancer incidentally found on [18F]fluorodeoxyglucose positron emission tomography/computed tomography during the staging workup for lung cancer Clin Lung Cancer 9 230 231 10.3816/CLC.2008.n.035 18650172
24. E Mittra M Vasanawala R Niederkohr C Rodriguez G Segall 2007 A case of three synchronous primary tumors demonstrated by F-18 FDG PET Clin Nucl Med 32 666 667 10.1097/RLU.0b013e3180a1ad48 17667450
25. HL van Westreenen M Westerterp PL Jager HM van Dullemen GW Sloof EF Comans, et al. 2005 Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer J Nucl Med 46 1321 1325 16085589
26. M Adriaensen L Schijf M de Haas J Huijbregts HJ Baarslag G Staaks, et al. 2008 Six synchronous primary neoplasms detected by FDG-PET/CT Eur J Nucl Med Mol Imaging 35 1931 10.1007/s00259-008-0821-2 18682942
27. JA Obando JM Samii M Yasrebi 2008 A case of two synchronous primary lung tumors demonstrated by FDG positron emission tomography Clin Nucl Med 33 775 777 10.1097/RLU.0b013e318187ef85 18936611
28. MD Wilkinson MJ Fulham BC McCaughan CJ Constable 2003 Differentiation of synchronous tumors using FDG positron emission tomography Clin Nucl Med 28 489 491 10.1097/00003072-200306000-00009 12917532
29. SL Aquino EF Halpern LB Kuester AJ Fischman 2007 FDG-PET and CT features of non-small cell lung cancer based on tumor type Int J Mol Med 19 495 499 17273799
30. MK Gould CC Maclean WG Kuschner CE Rydzak DK Owens 2001 Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis JAMA 285 914 924 1:STN:280:DC%2BD3M7ltF2isA%3D%3D 10.1001/jama.285.7.914 11180735
31. MK Gould WG Kuschner CE Rydzak CC Maclean AN Demas H Shigemitsu, et al. 2003 Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis Ann Intern Med 139 879 892 14644890
32. LF de Geus-Oei HF van der Heijden FH Corstens WH Oyen 2007 Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review Cancer 110 1654 1664 10.1002/cncr.22979 17879371
33. M MacManus U Nestle KE Rosenzweig I Carrio C Messa O Belohlavek, et al. 2009 Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 85 94 10.1016/j.radonc.2008.11.008 19100641
34. B Degirmenci D Wilson CM Laymon C Becker NS Mason B Bencherif, et al. 2008 Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography Nucl Med Commun 29 614 622 10.1097/MNM.0b013e3282f9b5a0 18528183
35. LF de Geus-Oei HF van der Heijden EP Visser R Hermsen BA van Hoorn JN Timmer-Bonte, et al. 2007 Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer J Nucl Med 48 1592 1598 10.2967/jnumed.107.043414 17873138
36. OC Schuurbiers JH Kaanders HF van der Heijden RP Dekhuijzen WJ Oyen J Bussink 2009 The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer J Thorac Oncol 4 761 767 10.1097/JTO.0b013e3181a1084f 19404218
37. CJ Jaskowiak JA Bianco SJ Perlman JP Fine 2005 Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values J Nucl Med 46 424 428 15750154
38. AA Lammertsma CJ Hoekstra G Giaccone OS Hoekstra 2006 How should we analyse FDG PET studies for monitoring tumour response? Eur J Nucl Med Mol Imaging 33 Suppl 1 16 21 10.1007/s00259-006-0131-5 16763817
39. Y Nakamoto KR Zasadny H Minn RL Wahl 2002 Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose Mol Imaging Biol 4 171 178 10.1016/S1536-1632(01)00004-X 14537140
40. C Nahmias LM Wahl 2008 Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors J Nucl Med 49 1804 1808 10.2967/jnumed.108.054239 18927325
41. CK Kim NC Gupta B Chandramouli A Alavi 1994 Standardized uptake values of FDG: body surface area correction is preferable to body weight correction J Nucl Med 35 164 167 1:STN:280:DyaK2c%2Fps1Wgug%3D%3D 8271040
42. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours (UICC). 6th ed. New York: Wiley; 2002.